CURE vs. TYD
CURE (Direxion Daily Healthcare Bull 3x Shares) and TYD (Direxion Daily 7-10 Year Treasury Bull 3X) are both exchange-traded funds - CURE is a Leveraged Equities fund tracking the Health Care Select Sector Index (300%), while TYD is a Leveraged Bonds fund tracking the NYSE 7-10 Year Treasury Bond Index. Both are passively managed. Over the past 10 years, CURE returned 13.44%/yr vs -5.21%/yr for TYD. At a correlation of -0.09, they often move in opposite directions. CURE charges 1.08%/yr vs 1.09%/yr for TYD.
Performance
CURE vs. TYD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a -6.55% return, which is significantly higher than TYD's -7.06% return. Over the past 10 years, CURE has outperformed TYD with an annualized return of 13.44%, while TYD has yielded a comparatively lower -5.21% annualized return.
CURE
- 1D
- 3.75%
- 1M
- 22.71%
- YTD
- -6.55%
- 6M
- 3.17%
- 1Y
- 35.85%
- 3Y*
- 4.56%
- 5Y*
- 1.36%
- 10Y*
- 13.44%
TYD
- 1D
- 0.77%
- 1M
- -3.53%
- YTD
- -7.06%
- 6M
- -6.67%
- 1Y
- 0.51%
- 3Y*
- -4.88%
- 5Y*
- -13.49%
- 10Y*
- -5.21%
CURE vs. TYD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | -6.55% | 22.55% | -8.47% | -9.40% | -20.51% | 88.30% | 5.02% | 55.66% | 2.82% | 69.32% |
TYD Direxion Daily 7-10 Year Treasury Bull 3X | -7.06% | 11.68% | -13.89% | -2.87% | -43.32% | -11.36% | 27.62% | 17.88% | 0.76% | 5.64% |
Correlation
The correlation between CURE and TYD is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.22 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.16 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.02 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2011 | -0.09 |
The correlation between CURE and TYD shifts across timeframes, from -0.09 (all time) to 0.30 (1 year), reflecting how their relationship changes across market environments.
CURE vs. TYD - Sectors Allocation Comparison
Sectors
CURE
TYD
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
CURE
TYD
-
Basic Materials
CURE
-
TYD
-
Communication Services
CURE
-
TYD
-
Consumer Cyclical
CURE
-
TYD
-
Consumer Defensive
CURE
-
TYD
-
Energy
CURE
-
TYD
-
Financial Services
CURE
-
TYD
Industrials
CURE
-
TYD
-
Real Estate
CURE
-
TYD
-
Technology
CURE
-
TYD
-
Utilities
CURE
-
TYD
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. TYD — Risk / Return Rank
CURE
TYD
CURE vs. TYD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily 7-10 Year Treasury Bull 3X (TYD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE | TYD | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.78 | ||
| Sortino ratioReturn per unit of downside risk | +1.30 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 1.02 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 1.16 | 0.04 | +1.12 |
| Martin ratioReturn relative to average drawdown | 2.64 | 0.10 | +2.54 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE | TYD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.81 | 0.04 | +0.78 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.03 | -0.59 | +0.62 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.27 | -0.26 | +0.53 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.05 | +0.43 |
Drawdowns
CURE vs. TYD - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, which is greater than TYD's maximum drawdown of -64.28%. Use the drawdown chart below to compare losses from any high point for CURE and TYD.
Loading charts...
Drawdown Indicators
| CURE | TYD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -64.28% | -4.91% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -13.54% | -17.56% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | -24.62% | -27.31% |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | -59.84% | +7.61% |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | -64.28% | -4.91% |
Current DrawdownCurrent decline from peak | -25.83% | -59.61% | +33.78% |
Average DrawdownAverage peak-to-trough decline | -18.15% | -21.98% | +3.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.60% | 5.16% | +8.44% |
Volatility
CURE vs. TYD - Volatility Comparison
Direxion Daily Healthcare Bull 3x Shares (CURE) has a higher volatility of 14.56% compared to Direxion Daily 7-10 Year Treasury Bull 3X (TYD) at 4.20%. This indicates that CURE's price experiences larger fluctuations and is considered to be riskier than TYD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | TYD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.56% | 4.20% | +10.36% |
Volatility (6M)Calculated over the trailing 6-month period | 31.21% | 9.65% | +21.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 44.24% | 13.80% | +30.44% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.89% | 22.97% | +20.92% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.60% | 20.36% | +29.24% |
CURE vs. TYD - Expense Ratio Comparison
CURE has a 1.08% expense ratio, which is lower than TYD's 1.09% expense ratio.
Dividends
CURE vs. TYD - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.14%, less than TYD's 3.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.14% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% | 0.00% | 0.00% |
TYD Direxion Daily 7-10 Year Treasury Bull 3X | 3.26% | 2.97% | 3.10% | 2.71% | 0.55% | 0.00% | 9.80% | 0.92% | 1.10% | 0.01% | 6.84% | 1.65% |
Frequently Asked Questions
CURE and TYD have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CURE has higher volatility (14.56%) compared to TYD (4.20%). In terms of maximum drawdown, CURE dropped -69.19% vs TYD's -64.28%.
On 10-year performance, CURE leads with 13.44% vs -5.21% for TYD. On fees, CURE is cheaper at 1.08% per year. On volatility, TYD has been the lower-risk option at 4.20%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, CURE has performed better with a 13.44% return vs -5.21%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
CURE is cheaper with a 1.08% expense ratio, compared with 1.09% for TYD.
TYD has the higher dividend yield at 3.26%, compared with 1.14% for CURE.
CURE is categorized as Leveraged Equities, while TYD is Leveraged Bonds. CURE tracks Health Care Select Sector Index (300%), while TYD tracks NYSE 7-10 Year Treasury Bond Index. Their fees differ too: 1.08% for CURE and 1.09% for TYD.
CURE currently has the higher Sharpe Ratio (0.81 vs 0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and TYD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer